Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Exelixis to Release Fourth Quarter and Fiscal Year 2023 Financial Results on Tuesday, February 6, 2024


Exelixis, Inc. (Nasdaq: EXEL) announced today that its fourth quarter and fiscal year 2023 financial results will be released on Tuesday, February 6, 2024 after the markets close. At 5:00 p.m. ET / 2:00 p.m. PT, Exelixis management will host a conference call and webcast to discuss the results and provide a general business update. Access to the event is available via the Internet from the company's website.

To access the conference call, please register using this link. Upon registration, a dial-in number and unique PIN will be provided to join the call. To access the live webcast link, log onto www.exelixis.com and proceed to the Event Calendar page under the Investors & News heading. A webcast replay of the conference call will also be archived on www.exelixis.com for one year.

About Exelixis

Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by drug discovery and development excellence, we are rapidly evolving our product portfolio to target an expanding range of tumor types and indications with our clinically differentiated pipeline of small molecules, antibody-drug conjugates and other biotherapeutics. This comprehensive approach harnesses decades of robust investment in our science and partnerships to advance our investigational programs and extend the impact of our flagship commercial product, CABOMETYX® (cabozantinib). Exelixis is driven by a bold scientific pursuit to create transformational treatments that give more patients hope for the future. For information about the company and its mission to help cancer patients recover stronger and live longer, visit www.exelixis.com, follow @ExelixisInc on X (Twitter), like Exelixis, Inc. on Facebook and follow Exelixis on LinkedIn.

Exelixis, the Exelixis logo and CABOMETYX are registered U.S. trademarks.


These press releases may also interest you

at 14:11
Brains Earns Great Place to Work Certification for 7th Consecutive Year
Brains is proud to be Certifiedtm by Great Place To Work® for the 7th year in a row. The prestigious award is based entirely on what current employees say about their experience working at Brains....

at 14:08
Prismatic's G2 Awards Highlight Consistent Market Leadership in Embedded iPaaS
Prismatic, the only embedded iPaaS that empowers both developers and non-developers, has been named a Momentum Leader in embedded integration platforms in G2's summer Momentum Grid® Report. The company also earned G2's Leader, Best Usability, and...

at 14:05
Demotech Research Demystifies Increased Frequency of Litigation and Social Inflation
Joseph Petrelli, President, Demotech, Inc., who authorized and initiated Demotech's ground-breaking research project in March 2022 notes with pride,  "Demotech's research, undertaken by Todd Kozikowski, identified the business model that exacerbates...

at 14:00
Marine Biotechnology Market size is set to grow by USD 4.71 billion from 2024-2028, Increase in demand for biofuel to boost the market growth, Technavio
The global marine biotechnology market size is estimated to grow by USD 4.71 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 9.83% during the forecast period. Increase in demand for biofuel is...

at 13:50
Carbon Trade eXchange (CTX) Launches ITMO Carbon Auction: Investors Can Now Enter Most Important Carbon Market on Earth
The long awaited ITMO Auction is ready to take buyer Registration via the world´s first and leading global Voluntary Carbon platform, Carbon Trade Exchange (CTX). Carbon market brokers, investors plus new players like family offices or funds can...

at 13:46
K1 Completes Strategic Exit of GoCanvas to Nemetschek Group
K1 Investment Management ("K1"), one of the largest small-cap enterprise software investment firms, yesterday completed the sale of its portfolio company GoCanvas®. GoCanvas, a leading field worker collaboration software provider, was acquired by...

More news about Science and technology...


News published on and distributed by: